BOZEN, Sud-Tirol, Italy, April 26, 2010 Health Roboticstoday announced the upcoming cooperation with the International Society ofOncology Pharmacy Practitioners (ISOPP), B|Braun Melsungen, and the GeneralFaculty Hospital of Prague to host ISOPP delegates at its bi-annual congressto witness live demonstrations of CytoCare in an Oncology patient setting.CytoCare is the only robot in the world proven to compound hazardous sterileI.V. Admixtures. ISOPP 2010 delegates may reserve attendance to thisinvitation-only event (space limited) athttp://www.isopp2010.com/en/health-robotics.
CytoCare directly addresses the challenges of Oncology Pharmacy in the21st Century, as it has globally set the gold standard of automaticallyhandling the complex and dangerous tasks associated with hazardous CSP(Compounded Sterile Preparations), increasing quality of care, improvingpatient safety, and decreasing costs, with hospital pharmacy Installations inthe United States of America, United Kingdom, Australia, Japan, Malaysia,Taiwan, Germany, Italy, Belgium, Turkey, Saudi Arabia, Denmark, and CzechRepublic.
"As we are now approaching 60 global installations of CytoCare, it isindeed a pleasure to share with global ISOPP 2010 delegates the patient andpharmacy safety benefits that academic medical centers such as CharlesUniversity's General Faculty Hospital have derived from CytoCare over thelast 3 years, especially in contrast with the hype spread by our competitorswho after more than 20 years of unsubstantiated announcements[1,2] have yetto even attempt to install a single robot in a hospital pharmacy forchemotherapy use anywhere in the world" stated Werner Rainer, HealthRobotics' CEO.
ISOPP 2010 delegates are also invited to visit Health Robotics' booth(F04) at the ISOPP Congress May 5th through May 8th, 2010 and witnesspresentations and demonstrations of i.v.STATION (robot for adjuvanttherapies), OMM (Oncology Medication Management electronic medical record),and i.v.SOFT Assist (workflow engine for manual compounding of chemotherapyIV Admixtures), while Health Robotics' product specialists, European-basedstaff, and senior management will be available to answer delegates' questions.
About Health Robotics:
Health Robotics is the undisputed global leading supplier oflife-critical intra-venous medication robots, providing healthcare facilitiesin 5 continents with robotics technology and software automation solutionsdeployed utilizing virtual high-availability technology. Its world-leadingsolutions CytoCare(TM) [hazardous IVs], i.v.STATION(TM) [non-hazardous IVs],i.v.SOFT(TM) [workflow engine for manual compounding, powered byMEDarchiver], and TPNstation(TM) [totally-automated parenteral nutrition]have and will greatly contribute to ease hospitals' growing pressures toimprove patient safety, increase throughput and contain costs. Through theeffective and efficient production of sterile, accurate, tamper-evident andready-to-administer IVs, Health Robotics' solutions help hospitals eliminatelife-threatening drug-exchange errors, decrease other therapy oversights andsterility risks, work more efficiently, reduce waste and controlledsubstances' diversion, and diminish the gap between rising patientvolume/acuity and scarce nursing and pharmacy staff. For more information,please visit http://www.health-robotics.com---------------------------------  http://www.intelligenthospitals.com/news-pr-2006-06-26.html  Am J Hosp Pharm 46(11): 2286-93 1989 For additional information, please contact: Health Robotics S.r.l. Claudia Flaim Marketing Coordinator Italy: +39-0471-200-372 email@example.com
SOURCE Health Robotics